Initial Slate of Company Presentations Coming Soon!
The Cell & Gene Meeting on the Mediterranean will feature presentations by 40+ leading public and private companies, highlighting technical and clinical achievements over the past 12 months in the areas of cell therapy, gene therapy, gene editing, tissue engineering and broader regenerative medicine technologies.
The company presentation application period has now closed. The initial slate of company presentations will be announced in early December.
Company MUST be an ARM member in good standing. Non-members interested in joining the organization should contact Perla Corredor at email@example.com for further details.
CEO or company C-Level executive MUST be available to present. Should a C-level executive not be available in the end, the presentation spot will be given to another company on the waitlist.
Priority selection is given to public and late-stage, private therapeutic developers as well as enabling technology companies. Service and tools providers are still able to apply and will be given consideration if space allows.
There is NO FEE to give a company presentation, however, presenters and any additional company attendees are required to register and pay to attend the conference.
Benefits of Presenting
Opportunity to feature your company in front of more than 250 top executives in the cell and gene therapy field
Opens the door for potential funding and partnership deals
Extensive exposure to all major industry players including big pharma, large biotech, disease philanthropies, investors and major research institutions and foundations